glp 1 agonists for type 2 diabetes GLP-1 receptor individualized treatment of mellitus GLP-1 receptor agonists are increasingly

Geroprotective and Anticarcinogenic Activity Lifetime Murine Studies Long-term studies in mice demonstrated that DSIP administration over a lifetime decreased total spontaneous tumour incidence 2.6-fold compared to untreated controls, slowed age-related switching-off of oestrous function, decreased the frequency of chromosome aberrations in bone marrow cells by 22.6%, and increased maximum lifespan by 24.1% compared to control groups a multi-parameter geroprotective profile that is among the most striking reported for any short regulatory peptide, and that has generated sustained interest in the DSIP analogue research field

c tnh chng oxy ha ca vitamin C gip c ch hot ng ca gc oxy ha - th c th ph hy collagen v khin bn nhanh b lo ha hn

Unfortunately, no one yet knows

Strength available: 10mg